Similar articles

• [Immunogenicity and reactogenicity of acellular pertussis vaccines intended for adolescent and adults].

  Zawadka M, Lutyńska A. Zawadka M, et al. Przegl Epidemiol. 2012;66(1):99-105. Przegl Epidemiol. 2012. PMID: 22708307 Polish.
• Research aims to boost pertussis control.

  Friedrich MJ. Friedrich MJ. JAMA. 2011 Jul 6;306(1):27-9. doi: 10.1001/jama.2011.888. JAMA. 2011. PMID: 21730232 No abstract available.
• Effectiveness of adolescent and adult tetanus, reduced-dose diphtheria, and acellular pertussis vaccine against pertussis.

  Wei SC, Tatti K, Cushing K, Rosen J, Brown K, Cassiday P, Clark T, Olans R, Pawloski L, Martin M, Tondella ML, Martin SW. Wei SC, et al. Clin Infect Dis. 2010 Aug 1;51(3):315-21. doi: 10.1086/653938. Clin Infect Dis. 2010. PMID: 20578875
• Update on adolescent immunization: review of pertussis and the efficacy, safety, and clinical use of vaccines that contain tetanus-diphtheria-acellular pertussis.

  Wilson TR. Wilson TR. J Pediatr Health Care. 2006 Jul-Aug;20(4):229-37. doi: 10.1016/j.pedhc.2005.12.011. J Pediatr Health Care. 2006. PMID: 16831630 Review.
• [Consensus on the clinical and microbiologic diagnosis of Bordetella pertussis, and infection prevention. Expert Group on Pertussis Vaccination].

  Grupo de expertos en vacunación contra tos ferina; Beltrán Silva S, Cervantes Apolinar Y, Cherry JD, Conde González C, Gentile A, Gómez Altamirano CM, Hernández Porras M, Huerta García G, Macías Parra M, Martínez Aguilar G, Mascareñas de los Santos A, Moreno Espinosa S, Pacheco Ríos A, Prado Cohrs D, Rodriguez Weber MA, Romano Mazzotti L, Rosales Uribe E, Sifuentes Osornio J, Ulloa-Gutiérrez R, Villaseñor Sierra A. Grupo de expertos en vacunación contra tos ferina, et al. Salud Publica Mex. 2011 Jan-Feb;53(1):57-65. doi: 10.1590/s0036-36342011000100009. Salud Publica Mex. 2011. PMID: 21340141 Spanish.